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Purpose: To determine the free fatty acid levels in the sera of patients with normal-tension 
glaucoma and compare it with that of normal controls.
Methods: Forty-four consecutive patients with newly diagnosed normal-tension glaucoma and 
forty-four age and gender matched controls were evaluated. The type and level of fatty acids 
in the sera were measured by gas chromatography (Model GC17A; Shimazu, Kyoto, Japan). 
Twenty-four fatty acids were identified from 12:0 to 24:1. The values were compared between 
the normal-tension glaucoma and control groups by Mann–Whitney U tests.
Results: No statistically significant difference was found in the levels of any free fatty acids 
between the normal-tension glaucoma group and control group.
Conclusion: No significant association was found in the serum free fatty acids levels including 
docosahexaenoic acid and eicosapentaenoic acid between normal-tension glaucoma patients 
and controls.
Keywords: free fatty acid, docosahexaenoic acid, eicosapentaenoic acid, normal tension 
glaucoma
Introduction
Glaucoma is the second leading cause of blindness in the world, affecting 700 million 
people, and is the leading cause of blindness in Japan affecting four million people.1 
Elevated intraocular pressure (IOP) is a major risk factor for the progression of glauco-
matous optic neuropathy.2,3 However, the 24-hour IOPs of some patients remain within the 
normal range, the so-called normal-tension glaucoma (NTG) patients. In Japan, in 92% of   
patients with primary open-angle glaucoma (POAG), the IOP was 21 mm Hg or less.1
The n-3 and n-6 polyunsaturated free fatty acids (PUFAs) are essential nutrients, 
but cannot be synthesized by mammalians and have to be ingested in the diet. The 
PUFAs, including docosahexaenoic acid (DHA), α-linolenic acid, and eicosapentanoic 
acid (EPA) have been shown to have neuroprotective and anti-inflammatory actions, 
and are implicated in the pathogenesis of some degenerative retinal diseases and neu-
rodegerative disease.4–7 Kang and colleagues showed there was a positive association 
between the dietary intake of the n-3 to n-6 polyunsaturated fat dietary intake and the 
risk of POAG. This association was stronger for patients with high-tension POAG.8
Relevant to NTG, Shimazawa and colleagues showed that DHA has neuroprotec-
tive effects against oxidative stress in retinal ganglion cells in vitro.9 Nguyen and col-
leagues reported that a n-3 deficient diet induced a significant decrease (−27.4%) in 
the scotopic threshold response of the electroretinogram which represents the activity 
of the retinal ganglion cells.10Clinical Ophthalmology 2010:4 92
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We hypothesized that a decrease in the level of serum n-3 
causes ganglion cell dysfunction and is the cause of clinical 
manifestations, namely, optic disc cupping, glaucomatous 
visual field defects, in patients with normal tension glaucoma. 
To test this hypothesis, we measured the level of n-3 and n-6 
PUFAs in the serum of patients with NTG and compared it 
to the level in normal healthy controls.
Methods
Forty-four consecutive patients (20 men, 24 women; average 
age ± standard deviation, 59.9 ± 9.8 years) with newly 
diagnosed NTG who came to the Glaucoma Clinic of Keio 
University Hospital from January 2005 to May 2007 were 
studied. The procedures used conformed to the Tenets of 
the Declaration of Helsinki. A written informed consent 
was obtained from all subjects. This study was approved 
by the Ethics Committee of the Keio University School of 
Medicine. All subjects underwent a complete ophthalmo-
logical examination including best-corrected visual acuity, 
slit-lamp biomicroscopy, pentacam corneal thickness evalua-
tion (Oculus Inc, Wetzlar, Germany), Goldmann applanation 
tonometry, gonioscopy, funduscopy, and optic disc evaluation 
with a 90-diopter lens by a single investigator (KY) with 
subspecialty training in glaucoma. In addition, perimetry 
was performed with a Humphrey field analysis using the 30-2 
Swedish Interactive Threshold Algorithm Standard Strategy 
(Carl Zeiss Meditec, Dublin, CA, USA).
The diagnostic criteria for NTG were; open anterior 
chamber angles on gonioscopy, glaucomatous optic disc 
cupping (cup-to disc ratio 0.7 with thinning or notching 
of the neural rim), and characteristic optic nerve-related 
visual field loss on Humphrey perimetry. All criteria were 
confirmed by at least a second visual field examination. 
Reliability was 20% fixation losses, 33% false-positive 
results, and 33% false negative results.
The diurnal IOP measurements was performed seven 
times at 6:00, 9:00, 12:00, 15:00, 18:00, 21:00, and 
24:00 hours. In all patients, the IOPs were 21 mm Hg. 
Seven patients were excluded because the highest diurnal IOP 
was 21 mm Hg. To eliminate the effect of central corneal 
thickness on the IOP, we re-calculated the IOP of the NTG 
patients by the following equation: corrected IOP = IOP 
reading −0.012 × (CCT in µm-520).11 The IOP of all the NTG 
patients was 21 mm Hg after the correction.
Subjects with other ophthalmic conditions such as angle 
closure glaucoma, pigment dispersion glaucoma, exfoliative 
glaucoma, trauma, any other type of secondary glaucoma, 
subjects aged below 40 or over 85 years, were excluded. 
None of the patients and controls had been taking vitamins, 
steroids, and had ever smoked.
The control subjects were recruited from patients who 
came to the clinic for annual ophthalmic check-up from Janu-
ary 2005 to May 2007. The 44 control subjects (16 men, 28 
women; average age ± standard deviation: 62.7 ± 14.8 years) 
did not have any history of ocular diseases, and underwent the 
same examinations as the patients by the same investigator. 
Humphrey visual field testing and central corneal thickness 
measurements were not performed in the control group 
because ocular examination results were normal.
Blood sampling
Fasting blood after 12 hours was collected from the forearm 
vein of all of the patients and controls in 5-ml tubes before 
noon. The blood samples were then centrifuged at 3000 g for 
10 minutes and stored at –80°C before the analyses.
Fatty acids were measured with a gas chromatograph 
(Model GC17A; Shimazu, Kyoto, Japan). A total of 24 fatty 
acids were identified from 12:0 to 24:1. The serum level of 
each fatty acid was expressed in µg/ml, and the ratio of n-3 
to n-6 polyunsaturated fatty acids was calculated.
statistical analyses
The age and IOP were compared between NTG and control 
groups by unpaired t-tests. Gender, prevalence of diabetes 
mellitus, and hypertension were compared between NTG and 
control groups by the Fisher’s exact test. The data between 
NTG and control groups were compared with Mann–Whitney 
U test. We also calculated the correlation between the IOP 
Table 1 Demographics of the nTg and control group. Data are 
expressed as mean ± standard deviation





Age (years) 59.9 ± 9.8 62.7 ± 14.8 0.19
Men/women 20/24 16/28 0.85
iOP right eye (mm hg) 16.0 ± 2.3 13.6 ± 2.5 0.001
iOP left eye (mm hg) 15.7 ± 2.5 14.2 ± 2.7 0.001
Mean deviation right eye (dB) −6.3 ± 7.8
Mean deviation left eye (dB) −6.2 ± 7.5
CCT right eye (µm) 526.5 ± 29.1
CCT left eye (µm) 523.9 ± 28.7
DM 4 (9.0%) 4 (9.0%) 0.92
hT 7 (15.9%) 2 (4.5%) 0.10
Notes: The iOP in Table 1 was not adjusted by calculation. 
Abbreviations: nTg, normal-tension glaucoma; iOP, intraocular pressure;   
CCT, central corneal thickness; DM, diabetes mellitus; hT, hypertension.Clinical Ophthalmology 2010:4 93
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No significant correlation was found between IOP and 
the level of each free fatty acid or the n-3/n-6 ratio in the 
normal control.
Discussion
Our findings showed that the serum levels of the free fatty 
acid in the patients with NTG did not differ significantly from 
that in the normal controls. We could not find any significant 
correlation between NTG and the free fatty acid levels includ-
ing EPA and DHA, which had been reported to be lower in 
POAG patients.12 The discrepancy of our results to those 
reported may be because the subjects of the earlier study were 
patients with POAG whose mean IOP was about 40 mm Hg, 
and our subjects had NTG with a mean IOP was in the normal 
range. The IOP depends on a balance in the production of 
aqueous humor by the ciliary body and the outflow through 
Table 2 Proportional concentrations of fatty acids in serum free fatty acid in nTg patients and healthy controls (µg/mL) and the ratio 
of n-3 to n-6 polyunsaturated fatty acids. No significant difference was shown in any fatty acids and the ratio of n-3 to n-6 long chain 
polyunsaturated fatty acids
Fatty acids  
numerical symbol
Common name n-x NTG group (n = 44) Control group (n = 44) P value
Mean SD Mean SD
12:0 Lauric acid 3.0 3.1 4.0 4.6 0.63
14:0 Myristic acid 33.8 18.9 37.4 23.9 0.65
14:1 Myristoleic acid n-5 0.0 0.0 0.0 0.0 1.00
16:0 Palmitic acid 783.9 254.2 764.5 259.0 0.92
16:1 Palmitoleic acid n-7 63.7 29.0 65.7 31.8 0.67
18:0 stearic acid 244.7 72.4 243.8 62.6 0.88
18:1 Oleic acid n-9 656.6 305.8 617.7 216.1 0.98
18:2 Linoleic acid n-6 923.1 231.5 900.5 177.7 0.83
18:3 (6,9,12) gamma-linolenic acid n-6 10.5 6.0 10.2 5.4 0.91
18:3 (9,12,15) Alpha-linolenic acid n-3 29.3 15.1 27.7 12.9 0.47
20:0 Arachidic acid 8.3 2.4 8.4 1.9 0.40
20:1 eicosenoic acid n-11 5.5 3.3 5.8 2.7 0.15
20:2 eicosadienoic acid n-6 6.6 1.9 6.5 1.8 0.89
20:3 (5,8,11) Mead acid n-9 2.1 1.4 1.9 1.0 0.91
20:3 (8,11,14) Dihomo-gamma-linolenic acid n-6 31.5 11.8 33.8 12.0 0.35
20:4 Arachidonic acid n-6 171.1 48.6 167.2 43.9 0.90
20:5 eicosapetaenoic acid n-3 96.4 46.7 94.6 59.1 0.55
22:0 Behenic acid 18.5 3.9 18.9 3.9 0.95
22:1 erucic acid n-9 1.6 0.7 1.7 0.8 0.85
22:4 Adrenic acid n-6 4.2 1.7 4.1 1.5 0.72
22:5 Osbond acid n-6 25.0 9.9 22.9 9.3 0.22
24:0 Lignoceric acid 16.6 3.5 16.6 3.3 0.66
22:6 Docosahexaenoic acid n-3 162.0 54.9 151.2 56.1 0.34
24:1 nervonic acid n-9 36.8 8.3 37.9 9.1 0.31
n-3/n-6 0.29 0.11 0.28 0.12 0.65
Abbreviations: nTg, normal-tension glaucoma; sD, standard deviation.
and the PUFAs by Pearson product-moment correlation coef-
ficient. A P-value less than 0.05 was considered statistically 
significant. Statistical analyses were performed with the 
SPSS statistical package for Windows (v. 15.00 SPSS Inc, 
Chicago, IL, USA).
Results
The clinical characteristics of the NTG patients and control 
subjects are shown in Table 1. No significant difference 
was found between the two groups in age, gender, and 
prevalence of diabetes mellitus and hypertension. The 
mean IOP was significantly higher in NTG patients than 
in normal controls.
The level of serum free fatty acids and the ratio of n-3 to 
n-6 polyunsaturated fatty acid level were not statistically dif-
ferent between NTG patients and healthy controls (Table 2).Clinical Ophthalmology 2010:4
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the trabecular meshwork. Evidence has been accumulating 
that the change in eyes with glaucoma are associated with 
oxidative stress. Nguyen and colleagues reported that increasing 
dietary n-3 reduces IOP with increasing age because of an 
increase in the outflow facility.13 Oxidative stress on the cells 
in the trabecular meshwork can lead to cellular dysfunction 
which then results in an elevation of the IOP. n-3 fatty acids, 
such as DHA and EPA, act as antioxidants, so reduction of 
the levels of DHA and EPA can cause oxidative changes in 
the cells in trabecular meshwork. This can then result in an 
IOP elevation.
There are limitations of our study. First, the small sample 
size, cross-sectional study design, and the large standard 
deviation observed for the fats make the conclusions less 
strong. Second, the serum fatty acid composition is influ-
enced by diet, and a dietary survey of patients and controls 
was not done. However, all of the NTG patients were newly 
diagnosed, so that the possibility of changing their diet may 
be relatively low. Therefore, a causal relationship has yet to 
be established in a large prospective study.
In conclusion, the level of free fatty acids in the sera of 
the patients with NTG did not differ significantly from that 
in the controls.
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